|
"hsieh rk"的相關文件
顯示項目 1-33 / 33 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2023-04-11 |
Carbohydrate antigen 19-9 response to initial adjuvant chemotherapy predicts survival and failure pattern of resected pancreatic adenocarcinoma but not which patients are suited for additional adjuvant chemoradiation therapy: From a prospective randomized
|
Chiu, YF;Liu, TW;Shan, YS;Chen, JS;Li, CP;Ho, CL;Hsieh, RK;Hwang, TL;Chen, LT;Ch'ang, HJ; Taiwan Cooperative Oncology Group pancreatic cancer study group, |
| 國家衛生研究院 |
2021-05 |
High expression of krüppel-like factor 10 or Smad4 predicts clinical benefit of adjuvant chemoradiotherapy in curatively resected pancreatic adenocarcinoma: From a randomized phase III trial
|
Pen, SL;Shan, YS;Hsiao, CF;Liu, TW;Chen, JS;Ho, CL;Chou, WC;Hsieh, RK;Chen, LT;Ch'ang, HJ |
| 中山醫學大學 |
2020 |
Satisfaction with pain management and impact of pain on quality of life in cancer patients
|
Lin, JS; Hsieh, RK; Chen, JS; Lee, KD; Rau, KM; Shao, YY; Sung, YC; Yeh, SP; Chang, CS; Liu, TC; Wu, MF; Lee, MY; Yu, MS; Yen, CJ; Lai, PY; Hwang, WL; Chiou, TJ |
| 國家衛生研究院 |
2018-10 |
Randomized, phase III trial comparing adjuvant gemcitabine (Gem) versus Gem plus chemoradiation (CCRT) in curatively resected pancreatic ductal adenocarcinoma (PDAC): A Taiwan cooperative oncology group study
|
Chang, HJ;Chiu, YF;Chen, JS;Li, CP;Ho, CL;Shyr, YM;Chiou, WC;Yeh, CN;Hsieh, RK;Lin, YL;Tien, YW;Hwang, TL;Shan, YS;Chen, LT |
| 國家衛生研究院 |
2017-07-31 |
The treatment patterns of non-metastatic prostate cancer in an Asian country
|
Huang, EYH;Yu, HJ;Chang, YH;Wu, TT;Cha, TL;Pang, ST;Huang, SP;Pan, CC;Cheng, JCH;Hsieh, RK;Peng, RS;Ku, HY;Liu, TW |
| 國家衛生研究院 |
2016-11-21 |
A phase I dose-escalation study of PEP02 (irinotecan liposome injection) in combination with 5-fluorouracil and leucovorin in advanced solid tumors
|
Chiang, NJ;Chao, TY;Hsieh, RK;Wang, CH;Wang, YW;Yeh, CG;Chen, LT |
| 國家衛生研究院 |
2015-05 |
A KRAS mutation status-stratified randomized phase II trial of gemcitabine and oxaliplatin alone or in combination with cetuximab in advanced biliary tract cancer
|
Chen, JS;Hsu, C;Chiang, NJ;Tsai, CS;Tsou, HH;Huang, SF;Bai, LY;Chang, IC;Shiah, HS;Ho, CL;Yen, CJ;Lee, KD;Chiu, CF;Rau, KM;Yu, MS;Yang, Y;Hsieh, RK;Chang, JY;Shan, YS;Chao, Y;Chen, LT |
| 國家衛生研究院 |
2014-12 |
Physician-patient end-of-life care discussions: Correlates and associations with end-of-life care preferences of cancer patients-a cross-sectional survey study
|
Tang, ST;Liu, TW;Liu, LN;Chiu, CF;Hsieh, RK;Tsai, CM |
| 國家衛生研究院 |
2014-07 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates among Taiwanese terminally ill cancer patients surveyed in 2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 臺北醫學大學 |
2014 |
Association between Phosphorylated AMP-Activated Protein Kinase and Acetyl-CoA Carboxylase Expression and Outcome in Patients with Squamous Cell Carcinoma of the Head and Neck
|
Su, YW;Lin, YH;Pai, MH;Lo, AC;Lee, YC;Fang, IC;Lin, J;Hsieh, RK;Chang, YF;Chen, CL |
| 臺北醫學大學 |
2014 |
Associations between accurate prognostic understanding and end-of-life care preferences and its correlates amongTaiwanese terminally ill cancer patients surveyed in2011–2012
|
Tang, ST;Liu, TW;Chow, JM;Chiu, CF;Hsieh, RK;Chen, CH;Liu, LN;Feng, WL |
| 國家衛生研究院 |
2011-12 |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-Fluorouracil/Leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: A Taiwan cooperative oncology group phase II study
|
Ch'ang, HJ;Lin, YL;Wang, HP;Chiu, YF;Chang, MC;Hsu, CH;Tien, YW;Chen, JS;Hsieh, RK;Lin, PW;Shan, YS;Cheng, AL;Chang, JY;Whang-Peng, J;Hwang, TL;Chen, LT |
| 國家衛生研究院 |
2011-08-17 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan
|
Chen, JS;Chao, Y;Hsieh, RK;Cheng, AL;Chen, PM;Chiou, TJ;Chao, TY;Yeh, KH;Chen, LT;Whang-Peng, J |
| 高雄醫學大學 |
2011 |
A phase II and pharmacokinetic study of first line S-1 for advanced gastric cancer in Taiwan.
|
趙毅;鄭安理;陳立宗;彭汪嘉康 ; Chen JS;Chao Y;Hsieh RK;Cheng AL;Chen PM;Chiou TJ;Chao TY;Yeh KH;Chen LT;Whang-Peng J. |
| 高雄醫學大學 |
2011 |
Induction chemotherapy with gemcitabine, oxaliplatin, and 5-fluorouracil/leucovorin followed by concomitant chemoradiotherapy in patients with locally advanced pancreatic cancer: a Taiwan cooperative oncology group phase II study.
|
陳立宗 ; Ch'ang HJ;Lin YL;Wang HP;Chiu YF;Chang MC;Hsu CH;Tien YW;Chen JS;Hsieh RK;Lin PW;Shan YS;Cheng AL;Chang JY;Whang-Peng J;Hwang TL;Chen LT. |
| 國家衛生研究院 |
2010-05 |
Phase I study of liposome irinotecan (PEP02) in combination with weekly infusion of 5-FU/LV in advanced solid tumors
|
Chen, L;Shiah, H;Chao, T;Hsieh, RK;Chen, G;Chang, J;Yeh, G |
| 國家衛生研究院 |
2010-04 |
A Randomized, Double-blind, Parallel, Comparative Study to Evaluate the Efficacy and Safety of Ramosetron plus Dexamethasone Injection for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting
|
Ho, CL;Su, WC;Hsieh, RK;Lin, ZZ;Chao, TY |
| 國家衛生研究院 |
2008-06 |
Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors
|
Lim, KH; Huang, MJ; Chen, LT; Wang, TE; Liu, CL; Chang, CS; Liu, MC; Hsieh, RK; Tzen, CY |
| 國家衛生研究院 |
2008-05 |
Cost-minimization analysis of capecitabine for advanced gastric cancer in Taiwan
|
Chang, CS;Chao, Y;Chen, JS;Chen, LT;Chung, CH;Hsieh, RK;Hwang, WS;Yang, L;De Reyder, F |
| 高雄醫學大學 |
2008 |
High efficacy of erlotinib in Taiwanese NSCLC patients in an exp;ed access program study previously treated with chemotherapy
|
黃明賢; Perng RP;Yang CH;Chen YM;Chang GC;Lin MC;Hsieh RK;Chu NM;Lai RS;Su WC;Tsao CJ;Hsia TC;Chen HC;Chen CH;Huang MS;Wang JL;Ho ML;Chung CY;Yu CJ;Chang WC;Kuo HP;Yu CT;Lin ZZ;Kao WY. |
| 國家衛生研究院 |
2006-07-17 |
An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer
|
Chao, Y; Li, CP; Chao, TY; Su, WC; Hsieh, RK; Wu, MF; Yeh, KH; Kao, WY; Chen, LT; Cheng, AL |
| 高雄醫學大學 |
2006 |
An open; multi-centre; phase II clinical trial to evaluate the efficacy and safety of paclitaxel; UFT; and leucovorin in patients with advanced gastric cancer.
|
陳立宗;鄭安理 ; Chao Y;Li CP;Chao TY;Su WC;Hsieh RK;Wu MF;Yeh KH;Kao WY;Chen LT;Cheng AL. |
| 國家衛生研究院 |
2005-06 |
An open, multi-center, phase II clinical trial to evaluate efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer preliminary report
|
Chao, Y;Li, CP;Chao, TY;Su, WC;Hsieh, RK;Wu, MF;Yeh, KH;Chen, LT;Cheng, AL |
| 國家衛生研究院 |
2004-08-02 |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer
|
Chao, Y; Yeh, KH; Chang, CJ; Chen, LT; Chao, TY; Wu, MF; Chang, CS; Chang, JY; Chung, CY; Kao, WY; Hsieh, RK; Cheng, AL |
| 國立臺灣大學 |
2004-08 |
Phase II study of weekly oxaliplatin and 24-hour infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.
|
Chao Y; Kun-Huei Yeh; Chang CJ; Chen LT; Chao TY; Wu MF; Chang CS; Chang JY; Chung CY; Kao WY; Hsieh RK; Cheng AL |
| 國家衛生研究院 |
2004 |
Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens
|
Hsieh, RK; Chao, TY; Chen, WS; Yang, TS; Chen, LT; Chen, PM; Liu, JH |
| 高雄醫學大學 |
2004 |
Oxaliplatin added to simplified bimonthly low-dose leucovorin and 5-FU for pretreated advanced colorectal cancer is effective and not affected by different previous 5-FU regimens.
|
陳立宗; Hsieh RK;Chao TY;Chen WS;Yang TS;Chen LT;Chen PM;Liu JH |
| 高雄醫學大學 |
2004 |
Phase II study of weekly oxaliplatin and 24-h infusion of high-dose 5-fluorouracil and folinic acid in the treatment of advanced gastric cancer.
|
趙毅;陳立宗;張俊彥; Chao Y;Yeh KH;Chang CJ;Chen LT;Chao TY;Wu MF;Chang CS;Chang JY;Chung CY;Kao WY;Hsieh RK;Cheng AL. |
| 國家衛生研究院 |
1999-06-15 |
Fulminant hepatitis is significantly increased in hepatitis B carriers after allogeneic bone marrow transplantation
|
Chen, PM; Chiou, TJ; Fan, FS; Liu, JM; Hsieh, RK; Yen, CC; Wang, WS; Liu, JH |
| 國家衛生研究院 |
1998-07 |
Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan, a region with a high prevalence of endemic viral infections
|
Liu, JM; Chen, YM; Chao, Y; Liu, SM; Tiu, CM; Wu, HW; Chiou, TC; Hsieh, RK; Whang-Peng, J |
| 高雄醫學大學 |
1998 |
Continuous infusion cisplatin and etoposide chemotherapy for cancer of unknown primary site (CUPS) in Taiwan; a region with a high prevalence of endemic viral infections.
|
陳立宗; Liu JM;Chen YM;Chao Y;Liu SM;Tiu CM;Wu HW;Chiou TC;Hsieh RK;Chen LT;Whang-Peng J |
| 國家衛生研究院 |
1997-02 |
Cross sectional study of use of alternative medicines in Chinese cancer patients
|
Liu, JM; Chu, HC; Chin, YH; Chen, YM; Hsieh, RK; Chiou, TJ; Whang-Peng, J |
| 國家衛生研究院 |
1997 |
The effect of subcutaneous r-HuEPO in cancer patients receiving chemotherapy with anemia: A preliminary report
|
Chiou, TJ; Chim, YS; Wei, CH; Hsieh, RK; Chen, PM |
顯示項目 1-33 / 33 (共1頁)
1
每頁顯示[10|25|50]項目
|
